Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: John Miz who wrote (24830)	12/9/1998 3:14:00 PM
From: Logistics	Read Replies (1) \| Respond to of 119973

ASTM from briefing.com Just out: 14:59 ET Aastrom Biosciences (ASTM) 5 3/4 +3 7/32 (+127%): Biotech shares rallying amid further evidence of the safety and clinical utility of company's stem cell therapy for cancer patients ASTM will use the data to support European marketing efforts to begin later this year, and to establish the use of the AastromReplicell System for production of bone marrow and cord blood cells for transplantation. News was released two days ago; see press release. Volume 4.7 mln; intraday range 2 3/8 to 6 1/2.